Real-time enrollment status for this preclinical alzheimer's disease clinical trial
Current Status
Recruiting
Checked: October 14, 2026 at 6:27 AM UTC
| NCT Number | NCT07794670 |
| Recruiting Status | Recruiting |
| Condition | Preclinical Alzheimer's Disease |
| Phase | PHASE2 |
| Target Enrollment | 400 participants |
| Active Locations | 1 sites in the US |
| Sponsor | NewAmsterdam Pharma |
| Last Updated on CT.gov | September 28, 2026 (2 weeks ago) |
As of October 14, 2026: Clinical trial NCT07794670 is currently recruiting participants. This phase2 study for preclinical alzheimer's disease is actively seeking new participants at 1 location across the United States. The study is sponsored by NewAmsterdam Pharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07794670 is actively recruiting participants as of October 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07794670 was last updated 2 weeks ago (September 28, 2026). HelloStudys verifies this status automatically.